The US healthcare CDMO market is estimated to grow significantly during the forecast period. The major factors that are projected to contribute to the growth of the market include the presence of contract manufacturers in the US that has significantly minimized costs and reduce product development time. Moreover, the growing demand for generic drugs, the rising number of drug development processes, and the emergence of several new market players in the pharmaceutical industry are some other crucial factors that are propelling the market in the US.

Get Free Sample Copy @ https://www.omrglobal.com/request-sample/us-healthcare-cdmo-market

The US market for healthcare CDMO is segregated on the basis of services and region. Based on services, the market is further classified into contract development and contract manufacturing. The contract manufacturing services segment is projected to have a significant share in the US healthcare CDMO market owing to the significant adoption of outsourcing services by pharmaceutical companies across the globe. The contract development services are further classified into clinical, preclinical, and laboratory services.

A Full Report of US Healthcare CDMO Market is Available at: https://www.omrglobal.com/industry-reports/us-healthcare-cdmo-market

The clinical segment is projected to have significant growth in the market owing to increasing clinical research. Moreover, the contract manufacturing services segment is further classified into API, finished dosage formulations, and medical devices. The API contract manufacturing services segment is significantly contributing to the growth of the market during the forecast period.
The companies which are contributing to the growth of the US healthcare CDMO market include AbbVie Inc., Baxter International, Inc., Catalent, Inc., Pfizer Inc., Thermo Fisher Scientific Inc., Jabil Inc., and others. Product launch, merger, and acquisition, collaborations with government, and technological advancements through which market players are considerably contributing to the market growth to stay competitive in the market.


US Healthcare CDMO Market – Segmentation
US Healthcare CDMO Market by Services
• Contract Development
• Clinical
• Preclinical
• Laboratory Services
• Contract Manufacturing
• Active Pharmaceutical Ingredients( API)
• Finish Dosage Formulations
• Medical Devices


US Healthcare CDMO Market – Segment by Region
North America
• United States
• Canada

Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World
• Latin America
• Middle East and Africa

Company Profiles
• AbbVie Inc.
• Baxter International, Inc.
• Catalent Inc.
• Covance Inc.
• Cambrex Corp.
• Hisun Pharmaceuticals Inc.
• Jabil Inc.
• Pfizer Inc.
• Stason Pharmaceuticals, Inc.
• Thermo Fisher Scientific Inc.


For More Customized Data, Request for Report Customization@
https://www.omrglobal.com/report-customization/us-healthcare-cdmo-market



About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]